X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer.

Qi-Chao Yang | Shuo Wang | Yuan-Tong Liu | An Song | Zhi-Zhong Wu | Shu-Cheng Wan | Hui-Min Li | Zhi-Jun Sun
iScience | 2023

Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been demonstrated to play a critical role in regulating cholesterol homeostasis and T cell antitumor immunity. However, the expression, function, and therapeutic value of PCSK9 in head and neck squamous cell carcinoma (HNSCC) remain largely unexplored. Here, we found that the expression of PCSK9 was upregulated in HNSCC tissues, and higher PCSK9 expression indicated poorer prognosis in HNSCC patients. We further found that pharmacological inhibition or siRNA downregulating PCSK9 expression suppressed the stemness-like phenotype of cancer cells in an LDLR-dependent manner. Moreover, PCSK9 inhibition enhanced the infiltration of CD8+ T cells and reduced the myeloid-derived suppressor cells (MDSCs) in a 4MOSC1 syngeneic tumor-bearing mouse model, and it also enhanced the antitumor effect of anti-PD-1 immune checkpoint blockade (ICB) therapy. Together, these results indicated that PCSK9, a traditional hypercholesterolemia target, may be a novel biomarker and therapeutic target to enhance ICB therapy in HNSCC.

Pubmed ID: 37305703 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

Rabbit (DA1E) mAb IgG XP Isotype Control (antibody)

RRID:AB_1550038

This isotype control targets not applicable

View all literature mentions

Rabbit monoclonal D4W2Z anti-CD8 (antibody)

RRID:AB_2756376

This recombinant monoclonal targets CD8

View all literature mentions

FoxP3 (D6O8R) Rabbit mAb (antibody)

RRID:AB_2797979

This monoclonal targets FOXP3

View all literature mentions

ALDH1A1 (D9Q8E) XP® Rabbit mAb (antibody)

RRID:AB_2799452

This monoclonal targets ALDH1A1

View all literature mentions

Sox2 (D1C7J) XP® Rabbit mAb (antibody)

RRID:AB_2798664

This monoclonal targets SOX2

View all literature mentions

PE anti-mouse IFN-gamma (antibody)

RRID:AB_315402

This monoclonal targets IFN-gamma

View all literature mentions

APC anti-mouse TNF-alpha (antibody)

RRID:AB_315429

This monoclonal targets TNF-alpha

View all literature mentions

PE anti-mouse Ly-6G (antibody)

RRID:AB_1186099

This monoclonal targets Ly-6G

View all literature mentions

APC anti-mouse Ly-6C (antibody)

RRID:AB_1732076

This monoclonal targets Ly-6C

View all literature mentions

FITC anti-mouse/human CD11b (antibody)

RRID:AB_312789

This monoclonal targets CD11b

View all literature mentions

PE anti-mouse CD279 (PD-1) (antibody)

RRID:AB_1877231

This monoclonal targets CD279

View all literature mentions

APC anti-mouse CD366 (Tim-3) (antibody)

RRID:AB_2562998

This monoclonal targets CD366

View all literature mentions

PerCP anti-mouse CD8a (antibody)

RRID:AB_893423

This monoclonal targets CD8a

View all literature mentions

FITC anti-mouse CD3 (antibody)

RRID:AB_312661

This monoclonal targets CD3

View all literature mentions

GAPDH antibody (antibody)

RRID:AB_2737588

This monoclonal targets GAPDH

View all literature mentions

Beta Actin antibody (antibody)

RRID:AB_2883836

This monoclonal targets Beta Actin

View all literature mentions

CD133 (D2V8Q) XP(R) (antibody)

RRID:AB_2721172

This monoclonal targets CD133

View all literature mentions

BMI1 antibody (antibody)

RRID:AB_2065392

This polyclonal targets BMI1

View all literature mentions

SREBF2 antibody (antibody)

RRID:AB_2881091

This polyclonal targets SREBF2

View all literature mentions

HMGCR antibody (antibody)

RRID:AB_2877957

This polyclonal targets HMGCR

View all literature mentions

LDLR antibody (antibody)

RRID:AB_2281164

This polyclonal targets LDLR

View all literature mentions

PCSK9 Antibody (antibody)

RRID:AB_2918134

This polyclonal targets PCSK9

View all literature mentions